Petach Tikva, Israel — November 24, 2025 — Leads & Copy — Nanox Imaging Ltd. (Nasdaq: NNOX) announced it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 3,826,530 ordinary shares in a registered direct offering expected to close around November 25, 2025.
The offering is projected to generate gross proceeds of approximately $15 million, before deducting offering expenses. The closing of the offering is subject to customary closing conditions.
Nanox intends to allocate the net proceeds from the offering to bolster working capital and for general corporate purposes.
Erez Meltzer, Chief Executive Officer of Nanox, stated that this capital raise will strengthen the company’s balance sheet and accelerate key growth initiatives. These initiatives include advancing the company’s technologies, expanding market presence, and enhancing its AI infrastructure. Meltzer expects these efforts to reinforce Nanox’s growth trajectory and improve access to high-quality medical imaging worldwide as they scale deployments and expand capabilities.
Titan Partners Group, a division of American Capital Partners, is serving as the sole placement agent for the offering.
The offering is being made pursuant to an effective shelf registration statement on Form F-3 (File No. 333-271688) previously filed with the U.S. Securities and Exchange Commission (SEC) under the Securities Act of 1933.
The offering of these securities will be made only through a prospectus and related prospectus supplement describing the terms of the offering, which will be filed with the SEC and available on the SEC’s website.
Electronic copies of the final prospectus supplement and accompanying prospectus can be obtained from Titan Partners Group LLC. Contact them at 4 World Trade Center, 49th Floor, New York, NY 10007, by telephone at 929-833-1246, or by email at prospectus@titanpartnersgrp.com.
This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor will there be any offer, solicitation, or sale of these securities in any jurisdiction where such action would be unlawful prior to registration or qualification under securities laws.
Nanox (NASDAQ: NNOX) aims to drive the world’s transition to preventive healthcare with affordable medical imaging technologies based on advanced AI and proprietary digital X-ray sources.
Nanox’s ecosystem includes Nanox.ARC, Nanox.AI LTD, Nanox.CLOUD, and Nanox.MARKETPLACE.
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com
Source: Nanox
